The histone deacetylase inhibitor trichostatin A induces GADD45γ expression via Oct and NF-Y binding sites

Oncogene

Volumn 27, Issue 9, 2008, Pages 1263-1272

  Campanero, M R ^a   Herrero, A ^b   Calvo, V ^b  

^a CSIC   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

GADD45 ; HDAC inhibitor; NF Y; Oct; TSA

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN GAMMA 45; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; NUCLEOTIDE; OCTAMER TRANSCRIPTION FACTOR; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTAGENESIS, SITE-DIRECTED; NIH 3T3 CELLS; OCTAMER TRANSCRIPTION FACTORS; POINT MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; SEQUENCE DELETION;

EID: 39749099976     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210735     Document Type: Article

References (50)

1. Balliet AG, Hollander MC, Fornace Jr AJ, Hoffman B, Liebermann DA. (2003). Comparative analysis of the genetic structure and chromosomal mapping of the murine GADD45g/CR6 gene. DNA Cell Biol 22: 457-468.
2. Beadling C, Johnson KW, Smith KA. (1993). Isolation of interleukin 2-induced immediate-early genes. Proc Natl Acad Sci USA 90: 2719-2723.
3. Berger SL. (2002). Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12: 142-148.
4. Brockman JL, Schuler LA. (2005). Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter. Mol Cell Endocrinol 239: 45-53.
5. Campanero MR, Armstrong M, Flemington E. (1999). Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol 19: 8442-8450.
6. Campanero MR, Armstrong M, Flemington E. (2000). CpG methylation as a mechanism for the regulation of E2F activity. Proc Natl Acad Sci USA 97: 6481-6486.
7. Caretti G, Salsi V, Vecchi C, Imbriano C, Mantovani R. (2003). Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J Biol Chem 278: 30435-30440.
8. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A et al. (2005). MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933-2942.
9. Chen Z, Clark S, Birkeland M, Sung CM, Lago A, Liu R et al. (2002). Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. Cancer Lett 188: 127-140.
10. Chung HK, Yi YW, Jung NC, Kim D, Suh JM, Kim H et al. (2003). GADD45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis. J Clin Endocrinol Metab 88: 3913-3920.
11. Constance CM, Morgan IV JI, Umek RM. (1996). C/EBPalpha regulation of the growth-arrest-associated gene GADD45. Mol Cell Biol 16: 3878-3883.
12. Della Ragione F, Criniti V, Della Pietra V, Borriello A, Oliva A, Indaco S et al. (2001). Genes modulated by histone acetylation as new effectors of butyrate activity. FEBS Lett 499: 199-204.
13. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin R, Jones J et al. (2001). Induction of GADD45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
14. Fan W, Richter G, Cereseto A, Beadling C, Smith KA. (1999). Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18: 6573-6582.
15. Hinkley C, Perry M. (1992). Histone H2B gene-transcription during Xenopus early development requires functional co-operation between proteins bound to the CCAAT and octamer motifs. Mol Cell Biol 12: 4400-4411.
16. Hirose T, Sowa Y, Takahashi S, Saito S, Yasuda C, Shindo N et al. (2003). p53-independent induction of GADD45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. Oncogene 22: 7762-7773.
17. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R et al. (1999). Genomic instability in GADD45a-deficient mice. Nat Genet 23: 176-184.
18. Huang W, Zhao S, Ammanamanchi S, Brattain M, Venkatasubbarao K, Freeman JW. (2005). Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1. NF-Y complex. J Biol Chem 280: 10047-10054.
19. Inoue T, Kamiyama J, Sakai T. (1999). Sp1 and NF-Y synergistically mediate the effect of vitamin D(3) in the p27(Kip1)gene promoter that lacks vitamin D response elements. J Biol Chem 274: 32309-32317.
20. Jiang F, Wang Z. (2004). GADD45γ is androgen-responsive and growth-inhibitory in prostate cancer cells. Mol Cell Endocrinol 213: 121-129.
21. Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P et al. (2001). Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage. Oncogene 20: 2683-2690.
22. Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X et al. (2002). GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 21: 8696-8704.
23. Johnstone RW. (2002). Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 1: 287-299.
24. Jung N, Yi YW, Kim D, Shong M, Hong SS, Lee HS et al. (2000). Regulation of GADD45γ expression by C/EBP. Eur J Biochem 267: 6180-6187.
25. Kakizawa T, Miyamoto T, Ichikawa K, Takeda T, Suzuki S, Mori J et al. (2001). Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor. J Biol Chem 276: 9720-9725.
26. Kojima S, Mayumi-Matsuda K, Suzuki H, Sakata T. (1999). Molecular cloning of rat GADD45gamma, gene induction and its role during neuronal cell death. FEBS Lett 446: 313-317.
27. Liebermann DA, Hoffman B. (2003). Myeloid differentiation (MyD) primary response genes in hematopoiesis. Blood Cells Mol Dis 31: 213-228.
28. Lu B, Ferrandino AF, Flavell RA. (2004). GADD45beta is important for perpetuating cognate and inflammatory signals in T cells. Nat Immunol 5: 38-44.
29. Lu B, Yu H, Chow C, Li B, Zheng W, Davis RJ et al. (2001). GADD45gamma mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14: 583-590.
30. Mantovani R. (1999). The molecular biology of the CCAAT-binding factor NF-Y. Gene 239: 15-27.
31. Mantovani R, Li XY, Pessara U, Hooft van Huisjduijnen R, Benoist C, Mathis D. (1994). Dominant negative analogs of NF-YA. J Biol Chem 269: 20340-20346.
32. Marhin WW, Chen S, Facchini LM, Fornace Jr AJ, Penn LZ. (1997). Myc represses the growth arrest gene GADD45. Oncogene 14: 2825-2834.
33. Mariadason JM, Corner GA, Augenlicht LH. (2000). Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res 60: 4561-4572.
34. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE et al. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
35. Nakayama K, Hara T, Hibi M, Hirano T, Miyajima A. (1999). A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth. J Biol Chem 274: 24766-24772.
36. Osborne A, Zhang H, Yang WM, Seto E, Blanck G. (2001). Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. Mol Cell Biol 21: 6495-64506.
37. Park SH, Lee SR, Kim BC, Cho EA, Patel SP, Kang HB et al. (2002). Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells. J Biol Chem 277: 5168-5174.
38. Peng Y, Jahroudi N. (2003). The NFY transcription factor inhibits von Willebrand factor promoter activation in non-endothelial cells through recruitment of histone deacetylases. J Biol Chem 278: 8385-8394.
39. Smith ML, Ford JM, Hollander MC, Bortnick RA, Amundson SA, Seo YR et al. (2000). p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/or GADD45 genes. Mol Cell Biol 20: 3705-3714.
40. Sun L, Gong R, Wan B, Huang X, Wu C, Zhang X et al. (2003). GADD45gamma, down-regulated in 65% hepatocellular carcinoma (HCC) from 23 Chinese patients, inhibits cell growth and induces cell cycle G2/M arrest for hepatoma Hep-G2 cell lines. Mol Biol Rep 30: 249-253.
41. Takahashi S, Saito S, Ohtani N, Sakai T. (2001). Involvement of the Oct-1 regulatory element of the GADD45 promoter in the p53-independent response to ultraviolet irradiation. Cancer Res 61: 1187-1195.
42. Takekawa M, Saito H. (1998). A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95: 521-530.
43. Vairapandi M, Balliet AG, Hoffman B, Liebermann DA. (2002). GADD45β and GADD45γ are cdc2/cyclinB1 kinase inhibitors with a role in S and G2/M cell cycle checkpoints induced by genotoxic stress. J Cell Physiol 192: 327-338.
44. Yang J, Zhu H, Murphy TL, Ouyang W, Murphy KM. (2001). IL-18-stimulated GADD45 beta required in cytokine-induced, but not TCR-induced, IFN-gamma production. Nat Immunol 2: 157-164.
45. Ying J, Srivastava G, Hsieh WS, Gao Z, Murray P, Liao SK et al. (2005). The stress-responsive gene GADD45γ is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors. Clin Cancer Res 11: 6442-6449.
46. Yokota T, Matsuzaki Y, Miyazawa K, Zindy F, Roussel MF, Sakai T. (2004). Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene 23: 5340-5349.
47. Zhan Q, Bae I, Kastan MB, Fornace Jr AJ. (1994). The p53-dependent gamma-ray response of GADD45. Cancer Res 54: 2755-2760.
48. Zhang W, Bae I, Krishnaraju K, Azam N, Fan W, Smith K et al. (1999). CR6: A third member in the MyD118 and GADD45 gene family which functions in negative growth control. Oncogene 18: 4899-48907.
49. Zhang W, Hoffman B, Liebermann DA. (2001). Ectopic expression of MyD118/GADD45/CR6 (GADD45beta/alpha/gamma) sensitizes neoplastic cells to genotoxic stress-induced apoptosis. Int J Oncol 18: 749-757.
50. Zhang X, Sun H, Danila DC, Johnson SR, Zhou Y, Swearingen B et al. (2002). Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis. J Clin Endocrinol Metab 87: 1262-12627.